Please try another search
For the fiscal year ended 31 December 2021, Moogene Medi Co Ltd revenues decreased 37% to W7.2M. Net loss increased 27% to W2.51B. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects R & D Expense increase from W419.1M to W952.2M (expense), Salaries & Wages increase of 39% to W504.4M (expense).
Period Ending: | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Total Revenue | 7.2 | 11.4 | 12.95 | 100.95 |
Gross Profit | ||||
Operating Income | -2475.72 | -1957.44 | -2049.11 | -1367.47 |
Net Income | -2510.6 | -1977.29 | -2083.9 | -1473.9 |
Period Ending: | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Total Assets | 8034.95 | 5474.41 | 3724.67 | 5398.64 |
Total Liabilities | 4839.53 | 186.87 | 438.17 | 366.13 |
Total Equity | 3195.41 | 5287.54 | 3286.51 | 5032.51 |
Period Ending: | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Period Length: | 12 Months | 12 Months | 12 Months | 12 Months |
Cash From Operating Activities | -1809.75 | -1351.75 | -1399.36 | -1239.98 |
Cash From Investing Activities | -2760.61 | -3812.25 | -3.76 | -624.32 |
Cash From Financing Activities | 4598.33 | 3356.9 | -13.99 | 6404.99 |
Net Change in Cash | 27.97 | -1807.1 | -1417.11 | 4540.69 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review